Global Tumour Ablation Market Trends by Key Vendors and Market Scenario Worth USD 3.5 Billion by 2024
The new report “Global Tumour Ablation Market” has accounted for USD 1.8 billion in 2016, expected to reach USD 3.5 billion by 2024, growing at a CAGR of 8.2% in the forecast period 2017 to 2024.
Pune, India – July 27, 2017 /MarketersMedia/ —
Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024
Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample?dbmr=global-tumour-ablation-market
The global tumour ablation market is expected to grow, owing to factors such as rising cancer incidence, increased focus on treatment of breast cancer, better reimbursement scenarios, shift towards value based reimbursements and continuous development in ablation technology. The ablation technology has an upper edge on chemotherapy and other oncology therapeutics.
The global tumour ablation market is segmented based on product types, cancer types, end-user and geography.
The global tumour ablation market is segmented into 3 type’s ablation systems, image guidance products and accessories. The ablation systems dominates the market and is further segmented based on product type into microwave ablation (coretherm thermotherapy devices and prolieve thermotherapy devices), radiofrequency ablation (RFA) ((temperature controlled devices, fluid cooled, catheter manipulation systems), high intensity focused ultrasound (HIFU), laser ablation and cryoablation. All ablation techniques are percutaneous except HIFU which is administered transcutaneously.
On the basis of cancer types treated using ablation devices the market is segmented into liver, lings, kidney, brain, bone, pancreas, breast and, other cancer types.
Based on end-user the global tumour ablation market is segmented into hospitals, oncology clinics and others.
Inquiry before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying?dbmr=global-tumour-ablation-market
Based on geography the Global Tumour Ablation Market is segmented into:
• North America
• South America
• Europe
• Asia-Pacific
• Rest of the World
The tumour ablation market’s major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
Some of the major companies operating in this market are:
• Galil Medical, Inc.
• Perseon Corporation
• NeuWave Medical, Inc.
• Koninklijke Philips N.V.
• INTIO Inc.
• Mermaid Medical A/S
• SonaCare Medical
• LLC
• DFINE, Inc.
• Misonix, Inc.
• BVM Medical Limited
• AngioDynamics, Inc.
• COMSOL Inc.
• Boston Scientific Corporation
• EDAP TMS S.A.
• HealthTronics, Inc.
Browse Full Report Visit @ http://databridgemarketresearch.com/reports/medical-devices/ablation-devices-medical-devices/global-tumour-ablation-market
Table of Content:
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. MARKET OVERVIEW
5. TUMOUR ABLATION MARKET, BY TYPE
5.1. OVERVIEW
5.2. TUMOUR ABLATION SYSTEMS
5.3. IMAGE GUIDANCE PRODUCTS
5.4. ACCESSORIES
6. TUMOUR ABLATION MARKET, BY CANCER TYPE
6.1. OVERVIEW
6.2. LIVER CANCER
6.3. BRAIN CANCER
6.4. LUNG CANCER
6.5. BONE CANCER
6.6. KIDNEY CANCER
6.7. PANCREATIC CANCER
6.8. BREAST CANCER
6.9. OTHERS
7. TUMOR ABLATION MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS
7.3. ONCOLOGY CLINICS
7.4. OTHERS
8. TUMOUR ABLATION MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE TUMOUR ABLATION MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
8.1.1. NORTH AMERICA
8.1.2. EUROPE
8.1.3. ASIA-PACIFIC (APAC)
8.1.4. LATIN AMERICA
8.1.5. REST OF THE WORLD
8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
9. TUMOUR ABLATION MARKET: COMPETITIVE LANDSCAPE
9.1. GLOBAL TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
9.2. NORTH AMERICA TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
9.3. EUROPE TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
9.4. APAC TUMOUR ABLATION MARKET: COMPANY SHARE ANALYSIS
9.5. MERGERS & ACQUISITIONS
9.6. NEW PRODUCT DEVELOPMENT & APPROVALS
9.7. EXPANSIONS
9.8. REGULATORY CHANGES
9.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
10. TUMOUR ABLATION MARKET, COMPANY PROFILES
10.1. MEDTRONIC
10.1.1 OVERVIEW
10.1.2 SWOT ANALYSIS
10.1.3 PRODUCT PORTFOLIO
10.1.4 REVENUE ANALYSIS
10.1.5 ANALYSTS VIEW
10.2. GALIL MEDICAL, INC.
10.2.1 OVERVIEW
10.2.2 SWOT ANALYSIS
10.2.3 PRODUCT PORTFOLIO
10.2.4 REVENUE ANALYSIS
10.2.5 ANALYSTS VIEW
10.3 PERSEON CORPORATION
10.3.1 OVERVIEW
10.3.2 SWOT ANALYSIS
10.3.3 PRODUCT PORTFOLIO
10.3.4 REVENUE ANALYSIS
10.3.5 ANALYST VIEW
10.4 NEUWAVE MEDICAL, INC.
10.4.1 OVERVIEW
10.4.2 SWOT ANALYSIS
10.4.3 PRODUCT PORTFOLIO
10.4.4 REVENUE ANALYSIS
10.4.5 ANALYSTS VIEW
10.5. KONINKLIJKE PHILIPS N.V.
10.5.1 OVERVIEW
10.5.2 SWOT ANALYSIS
10.5.3 PRODUCT PORTFOLIO
10.5.4 REVENUE ANALYSIS
10.5.5 ANALYSTS VIEW
10.6. INTIO INC.
10.6.1 OVERVIEW
10.6.2 SWOT ANALYSIS
10.6.3 PRODUCT PORTFOLIO
10.6.4 REVENUE ANALYSIS
10.6.5 ANALYSTS VIEW
10.7. MERMAID MEDICAL A/S
10.7.1 OVERVIEW
10.7.2 SWOT ANALYSIS
10.7.3 PRODUCT PORTFOLIO
10.7.4 REVENUE ANALYSIS
10.7.5 ANALYSTS VIEW
10.8. SONACARE MEDICAL, LLC
10.8.1 OVERVIEW
10.8.2 SWOT ANALYSIS
10.8.3 PRODUCT PORTFOLIO
10.8.4 REVENUE ANALYSIS
10.8.5 ANALYSTS VIEW
10.9. DFINE, INC.
10.9.1. OVERVIEW
10.9.2. SWOT ANALYSIS
10.9.3. PRODUCT PORTFOLIO
10.9.4. REVENUE ANALYSIS
10.9.5. ANALYSTS VIEW
10.10. MISONIX, INC.
10.10.1. OVERVIEW
10.10.2. SWOT ANALYSIS
10.10.3. PRODUCT PORTFOLIO
10.10.4. REVENUE ANALYSIS
10.10.5. ANALYSTS VIEW
10.11. BVM MEDICAL LIMITED
10.11.1. OVERVIEW
10.11.2. SWOT ANALYSIS
10.11.3. PRODUCT PORTFOLIO
10.11.4. REVENUE ANALYSIS
10.11.5. ANALYSTS VIEW
10.12. ANGIODYNAMICS, INC.
10.12.1. OVERVIEW
10.12.2. SWOT ANALYSIS
10.12.3. PRODUCT PORTFOLIO
10.12.4. REVENUE ANALYSIS
10.12.5. ANALYSTS VIEW
10.13. COMSOL INC.
10.13.1. OVERVIEW
10.13.2. SWOT ANALYSIS
10.13.3. PRODUCT PORTFOLIO
10.13.4. REVENUE ANALYSIS
10.13.5. ANALYSTS VIEW
10.14. BOSTON SCIENTIFIC CORPORATION
10.14.1. OVERVIEW
10.14.2. SWOT ANALYSIS
10.14.3. PRODUCT PORTFOLIO
10.14.4. REVENUE ANALYSIS
10.14.5. ANALYSTS VIEW
10.15. EDAP TMS S.A.
10.10.1. OVERVIEW
10.10.2. SWOT ANALYSIS
10.10.3. PRODUCT PORTFOLIO
10.10.4. REVENUE ANALYSIS
10.10.5. ANALYSTS VIEW
10.16. HEALTHTRONICS, INC.
11. APPENDIX
Related Report
Global Infection Control Market – Trends and Forecast to 2024
Global Infection Control Market, By Type (Disinfection (Medical Nonwovens, Disinfectants, Disinfectors (Washer, Flusher, U.V. Rays), Disinfectant Wipes, Endoscope Reprocessors), Sterilization (Products (Heat, Low Temperature, Radiation, Filtration), Services)), By Application, By End-User (Hospitals, Medical Device Manufacturers, Pharmaceutical Manufacturers, Food and Beverage Industry, Laboratory), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Trends and Forecast to 2024
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Info:
Name: Ankit Singh
Email: Sales@databridgemarketresearch.com
Organization: Data Bridge Market Research
Address: Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar, Pune – 411028
Phone: +1-888-387-2818
For more information, please visit http://databridgemarketresearch.com/reports/global-tumour-ablation-market/
Source: MarketersMedia
Release ID: 222379
Copyright © 1999-2013 SproutNews.com
